Rocket


Overview
Financials
News + Filings

 
 

EMULATE THERAPEUTICS, INC. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues0.71.52.1
            Revenue growth-57.2%-25.6% 
Cost of goods sold14.211.610.7
Gross profit-13.6-10.0-8.7
            Gross margin-2065.3%-653.2%-420.8%
General and administrative13.610.08.7
EBIT-14.0-11.3-10.6
            EBIT margin-2120.7%-737.5%-515.3%
Pre-tax income-21.6-22.12.6
Income taxes0.00.0-0.8
            Tax rate0.0%0.0% 
Net income-21.6-22.13.5
            Net margin-3284.0%-1438.3%167.5%
 
Diluted EPS($3.57)($4.02)$0.18
Shares outstanding (diluted)6.15.519.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy